Amini: From a radiation standpoint, this has changed the landscape of our field. A large proportion of my practice is stage IV disease, where patients who are on these excellent systemic therapies are ...
In the U.S., FDA approval establishes Opdivo in combination with doxorubicin, vinblastine and dacarbazine (AVD) as the first immunotherapy combination approved for adult and pediatric patients 12 ...
Amini: As a radiation oncologist, I do play a larger role than I feel we used to as our patients are living longer and cure rates are improving. We are no longer just seeing the short or subacute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results